Exane Derivatives’s Universal Health Services UHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-13
Closed -$1.88K 965
2022
Q1
$1.88K Buy
+13
New +$1.8K ﹤0.01% 759
2021
Q4
Sell
-13
Closed -$1.8K 1017
2021
Q3
$1.8K Hold
13
﹤0.01% 811
2021
Q2
$1.99K Hold
13
﹤0.01% 818
2021
Q1
$1.73K Hold
13
﹤0.01% 692
2020
Q4
$1.79K Hold
13
﹤0.01% 637
2020
Q3
$1.39K Buy
+13
New +$1.39K ﹤0.01% 593
2018
Q3
Sell
-13
Closed -$1.46K 728
2018
Q2
$1.46K Buy
+13
New +$1.52K ﹤0.01% 508

Other funds holding UHS

Exane Derivatives's UHS Position: Q2 2022 in Review

Exane Derivatives sold out of Universal Health Services (UHS) in Q2 2022, closing a stake of 13 shares — an estimated $1.88K sold.

Exane Derivatives first reported a position in UHS in Q2 2018 and held it in 7 quarters. The position peaked at $1.99K in Q2 2021. 432 funds tracked by Wall St. Rank hold UHS as of Q2 2022.

  • Exane Derivatives reported no remaining Universal Health Services position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 13 Universal Health Services shares in Q2 2022, an estimated $1.88K.
  • Exane Derivatives first reported a position in Universal Health Services in Q2 2018 and held it in 7 quarters.
  • Exane Derivatives's Universal Health Services position peaked at $1.99K in Q2 2021.
  • 432 funds tracked by Wall St. Rank held Universal Health Services as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.